|
|
|
|
Events
|
|
2007 SAPA-WEST Science & Technology Symposium -
Current Trends in Protein Therapeutics Development
|
|
| Type: |
Forum
|
| Time: |
1:00 PM - 5:30 PM
|
| Date: |
2007-03-17
|
| Location: |
Stanford Munzer Auditorium
Stanford, Palo Alto, California 94305
|
| Description: |
Agenda:
1:00 ~ 1:05 pm
Welcome / Opening Remarks
Science & Technology Committee, SAPA-West
1:05 ~ 1:50 pm
Avimers: Multivalent Therapeutic Proteins Derived From a Family of Human Receptor Domains
Kevin W. Moore, Ph.D. Scientific Executive Director?CAmgen Mountain View
1:50 ~ 2:35 pm
Preclinical Development of mAb: from XenoMouse Technology to Panitumumab
Xiaodong Yang, Ph.D. Vice President of Research and Preclinical Development, Intradigm (former Senior Director of Cancer Pharmacology, Abgenix and Amgen)
2:35 ~ 3:00 pm Break
3:00 ~ 3:45 pm
Production of Therapeutic Antibody for In Vivo Studies
Cheng Liu, Ph.D. President and CEO, Eureka Therapeutics, Inc.
3:45 ~ 4:30 pm
Monoclonal Antibody Formulation and Drug Product
Bao-Lu Chen, PhD, Associate Director, Formulation Development, Xencor
4:30 ~ 5:30 pm
Open discussion and social
|
| Admission: |
Free for paid SAPA-West members, Stanford students and Stanford post-doctors
$10 for others
|
| Organizers: |
SAPA-West Science & Technology Committee
(Shuli Zhang, Vice Chair of Science & Technology Committee)
|
|
|
|
|
|
|
